Our work highlights the HSF1 pathway as a therapeutic target in ALS patients with DNAJC7 mutations, and perhaps beyond68, as RNA-Seq analysis revealed a reduction in the expression of HSF1 pathway genes in sporadic and C9orf72 patient neurons. This evidence concerns the gene HSF1 and amyotrophic lateral sclerosis.